Table 1.
Patients | No. | Mean age ± SD |
---|---|---|
All gliomas | 63 | 53.29 ± 14.98 |
Sex (male/female) | 38/25 | |
Grades (male/female) | ||
G. II | 14/5 | 14/5 (40.47 ± 12.30) |
G. II-III | 2/0 | 2/0 (30.5) |
G. III | 7/4 | 7/4 (48.55 ± 12.57) |
G. III-IV | 0/1 | 0/1 (55) |
G. IV | 15/15 | 15/15 (64.07 ± 8.70) |
Primary diagnosis | 49 | |
Relapse | 13 | |
Unknown | 1 | |
Diagnosis | ||
Diffuse glioma II | 4 | |
Oligodendroglioma II | 7 | |
Oligoastrocytoma II | 1 | |
Astrocytoma II | 7 | |
Oligodendroglioma II-III | 1 | |
Astrocytoma II-III | 1 | |
Anaplastic astrocytoma | 11 | |
Anaplastic astrocytoma with signs of GBM | 1 | |
Primary GBM | 28 | |
Unknown GBM | 2 | |
Completely resected | ||
G. II | 4 | |
G. II-III | 0 | |
G. III | 3 | |
G. III-IV | 0 | |
G. IV | 4 | |
IDH1/2 mutated | 25 | |
G. II, III | 24 | |
G. IV | 1 | |
Steroid treated/untreated | ||
G. II | 7/12 | |
G. III | 9/4 | |
G. IV | 28/3 |
No.: number of patients; G.: grade; GBM: glioblastoma multiforme; IDH: isocitrate dehydrogenase.